Pharmanutra S.p.A. (BIT:PHN)
Italy · Delayed Price · Currency is EUR 82.50
+0.50 (0.61%)
Jul 28, 2026, 11:02 AM CET
Pharmanutra Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 21.16 | 18.58 | 15.49 | 18.93 | 22.05 | 29.41 |
Short-Term Investments | 7.84 | 12.04 | 13.48 | 6.19 | 4.81 | 4.53 |
Cash & Short-Term Investments | 29 | 30.62 | 28.97 | 25.12 | 26.86 | 33.94 |
Cash Growth | -5.71% | 5.67% | 15.34% | -6.49% | -20.86% | 63.14% |
Accounts Receivable | 28.26 | 24.76 | 22.05 | 19.22 | 21.65 | 16.67 |
Other Receivables | 0.53 | 0.84 | 0.55 | 1.11 | 2.08 | 0.94 |
Total Trade Receivables | 28.79 | 25.6 | 22.6 | 20.33 | 23.72 | 17.62 |
Inventory | 8.48 | 8.85 | 6.94 | 8.17 | 5.26 | 2.87 |
Other Current Assets | 8.39 | 7.83 | 6.5 | 5.07 | 2.88 | 1.1 |
Total Current Assets | 74.67 | 72.9 | 65.01 | 58.68 | 58.73 | 55.52 |
Net Property, Plant & Equipment | 24.07 | 24.13 | 25.66 | 26.36 | 17.06 | 8.37 |
Other Intangible Assets | 24.66 | 24.48 | 23.26 | 22.54 | 21.56 | 5.5 |
Long-Term Investments | 0.28 | 0.28 | 0.3 | 0.3 | 0.25 | 0.48 |
Other Long-Term Assets | 4.44 | 3.44 | 3.19 | 4.57 | 2.57 | 1.49 |
Total Assets | 128.13 | 125.23 | 117.41 | 112.44 | 100.16 | 71.36 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 17.52 | 19.9 | 15.8 | 16.11 | 16.89 | 9.75 |
Accrued Expenses | 3.86 | 1.56 | 2.56 | 3.11 | 1.52 | 3.43 |
Short-Term Debt | 4.66 | 5.06 | 4.76 | 4.59 | 3.62 | 0.82 |
Other Current Liabilities | 5.36 | 4.52 | 4.22 | 3.84 | 3.77 | 2.75 |
Total Current Liabilities | 31.4 | 31.03 | 27.34 | 27.65 | 25.79 | 16.75 |
Long-Term Debt | 14.44 | 15.45 | 19.51 | 23.43 | 14.11 | 5.53 |
Other Long-Term Liabilities | 7.82 | 7.51 | 8.43 | 6.96 | 9.31 | 4 |
Total Long-Term Liabilities | 22.26 | 22.96 | 27.93 | 30.39 | 23.42 | 9.53 |
Total Liabilities | 53.65 | 53.99 | 55.27 | 58.04 | 100.16 | 26.27 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.12 | 1.12 | 1.12 | 1.12 | 1.12 | 1.12 |
Treasury Stock | -5.9 | -5.9 | -4.56 | -4.01 | -2.36 | 0 |
Additional Paid-in Capital | 76.09 | 56.16 | 48.97 | 44.34 | 36.79 | 29.95 |
Accumulated Other Comprehensive Income | -0.18 | -0.04 | 0.03 | 0.12 | 0.12 | 0.01 |
Retained Earnings | 3.46 | 20 | 16.61 | 12.83 | 15.27 | 14 |
Total Common Shareholders' Equity | 74.6 | 71.35 | 62.16 | 54.41 | 50.95 | 45.08 |
Shareholders' Equity | 74.47 | 71.24 | 62.14 | 54.41 | 50.95 | 45.08 |
Total Liabilities & Equity | 128.13 | 125.23 | 117.41 | 112.44 | 151.1 | 71.36 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 19.1 | 20.51 | 24.27 | 28.02 | 17.73 | 6.35 |
Net Cash (Debt) | 9.91 | 10.1 | 4.7 | -2.9 | 9.14 | 27.59 |
Net Cash Growth | 47.74% | 114.91% | - | - | -66.89% | 44.14% |
Net Cash Per Share | 1.04 | 1.05 | 0.49 | -0.30 | 0.94 | 2.85 |
Book Value | 74.6 | 71.35 | 62.16 | 54.41 | 50.95 | 45.08 |
Book Value Per Share | 7.81 | 7.44 | 6.47 | 5.63 | 5.27 | 4.66 |
Tangible Book Value | 49.94 | 46.88 | 38.9 | 31.87 | 29.39 | 39.58 |
Tangible Book Value Per Share | 5.23 | 4.89 | 4.05 | 3.30 | 3.04 | 4.09 |